Related Experiment Video
Updated: Jan 27, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications
Salvatore Ulisse1, Chiara Tuccilli2, Salvatore Sorrenti3
1Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy. salvatore.ulisse@uniroma1.it.
Abstract:
The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to treat. Among these, there are the poorly differentiated and anaplastic thyroid cancers, unresponsive to all the therapies currently in use. In the present review we will summarize information regarding the expression of PD-L1 in the different thyroid cancer histotypes, its correlation with clinicopathological features, and its potential prognostic value. Then, we will evaluate the available data indicating the PD-1/PD-L1 axis as a promising target for thyroid cancer therapy.
Insights
New immunotherapies targeting programmed cell death 1 (PD-1) and PD-L1 offer hope for treating difficult thyroid cancers. Research explores PD-L1 expression and the PD-1/PD-L1 axis as a potential therapeutic target for these unresponsive cancers.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Thyroid cancers, particularly poorly differentiated and anaplastic types, are often resistant to current treatments.
- Immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its ligand PD-L1 shows promise in treating various cancers.
Purpose of the Study:
- To review the expression of PD-L1 in different thyroid cancer histotypes.
- To correlate PD-L1 expression with clinicopathological features and assess its prognostic value.
- To evaluate the PD-1/PD-L1 axis as a potential therapeutic target for thyroid cancer.
Main Methods:
- Literature review of studies on PD-L1 expression in thyroid cancer.
- Analysis of correlations between PD-L1 expression and clinicopathological parameters.
- Evaluation of preclinical and clinical data on PD-1/PD-L1 blockade in thyroid cancer.
Main Results:
- PD-L1 is expressed in various thyroid cancer histotypes, with varying frequencies.
- PD-L1 expression may correlate with specific clinicopathological features and potentially influence prognosis.
- Emerging data suggest the PD-1/PD-L1 pathway is a viable target for thyroid cancer immunotherapy.
Conclusions:
- Understanding PD-L1 expression in thyroid cancer is crucial for identifying potential responders to immunotherapy.
- The PD-1/PD-L1 axis represents a promising therapeutic avenue for refractory thyroid cancers.
- Further research is warranted to optimize PD-1/PD-L1 targeted therapies for thyroid cancer patients.
More Related Videos
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...